Type 1 Phototherapeutic Agents. 2. Cancer Cell Viability and ESR Studies of Tricyclic Diarylamines

ACS Med Chem Lett. 2012 Feb 16;3(4):284-8. doi: 10.1021/ml200266v. eCollection 2012 Apr 12.

Abstract

Type 1 phototherapeutic agents based on diarylamines were assessed for free radical generation and evaluated in vitro for cell death efficacy in the U937 leukemia cancer cell line. All of the compounds were found to produce copious free radicals upon photoexcitation with UV-A and/or UV-B light, as determined by electron spin resonance (ESR) spectroscopy. Among the diarylamines, the most potent compounds were acridan (4) and 9-phenylacridan (5), with IC50 values of 0.68 μM and 0.17 μM, respectively.

Keywords: Diarylamines; ESR; ROS; photosensitizers; radicals; type 1; type 2.